Stor forskel i behandling af depression mellem psykiatriske afdelinger

Ugeskrift for Laeger

Volumn 172, Issue 46, 2010, Pages 3183-3187

  Dam, Henrik ^a   Bendsen, Birgitte Bjerg ^a   Jakobsen, Klaus ^a   Larsen, Ejnar Bundgård ^a   Nilsson, Flemming Mørkeberg ^a   Pedersen, Anne Grethe Birch ^a   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL COMPETENCE; CLINICAL PRACTICE; COMPARATIVE STUDY; DENMARK; DEPRESSION; ELECTROCONVULSIVE THERAPY; FACTUAL DATABASE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; REGISTER;

ADULT; ANTIDEPRESSIVE AGENTS; CLINICAL COMPETENCE; DATABASES, FACTUAL; DENMARK; DEPRESSION; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC STATUS RATING SCALES; REGISTRIES; SEVERITY OF ILLNESS INDEX;

EID: 78650321230     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
2. Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technic. Postgrad Med 1972;52:81-5.
3. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 1997;45:5-17.
4. Judd LL, Akiskal HS, Maser JD et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97-108.
5. Judd LL, Paulus MJ, Schettler PJ et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-4.
6. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000;58:19-36.
7. Referenceprogram for unipolar depression. København: Sundhedsstyrelsen, 2007.
8. Ferreri M, Lavergne F, Berlin I et al. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. Acta Psychiatr Scand 2001;103:66-72.
9. Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 2002;51: 183-8.
10. Smith AH, Naylor GJ. The antidepressant properties of mianserin and its effect on sleep. Acta Psychiatr Belg 1978;78:813-26.
11. Winokur A, Sateia MJ, Hayes JB et al. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000;48:75-8.
12. Winokur A, McNally DP, Gary EM et al. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003;64:1224-9.
13. Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebocontrolled trials. J Clin Psychiatry 2007;68:935-40.
14. Bauer M, Forsthoff A, Baethge C et al. Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci 2003;253: 132-9.
15. Lepkifker E, Sverdlik A, Iancu I. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 2004;65:850-6.
16. Wijkstra J, Lijmer J, Balk FJ. Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. Br J Psychiatry 2006;188: 410-15.
17. Philip NS, Carpenter LL, Tyrka AR et al. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatr Pract 2008;14:34-44.
18. Baune BT. New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. Neuropsychiatr Dis Treat 2008;4:1181-91.
19. Stage KB. Depression. Rationel Farmakoter 2001;12:1-4.